Stifel raises Ionis Pharmaceuticals stock price target to $67 from $43

Investing.comMonday, October 6, 2025 at 2:11:18 PM
Stifel raises Ionis Pharmaceuticals stock price target to $67 from $43
Stifel has raised its price target for Ionis Pharmaceuticals from $43 to $67, reflecting a positive outlook on the company's future performance. This adjustment indicates confidence in Ionis's growth potential and could attract more investors, highlighting the company's advancements in drug development and market position.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Stifel reiterates Buy rating on Gambling.com stock, maintains $15 target
PositiveFinancial Markets
Stifel has reaffirmed its Buy rating on Gambling.com stock, maintaining a target price of $15. This is significant as it reflects confidence in the company's growth potential in the online gambling sector, which continues to expand rapidly. Investors may find this a promising opportunity, especially as the market evolves and more states legalize online gambling.
Stifel reiterates Datadog stock Hold rating amid OpenAI contract renewal
NeutralFinancial Markets
Stifel has maintained its Hold rating on Datadog's stock as the company navigates the renewal of its contract with OpenAI. This decision reflects a cautious approach amid ongoing developments in the tech sector. Investors are keenly watching how this contract renewal will impact Datadog's performance and market position, making it a significant point of interest for those involved in tech investments.
Stifel reiterates Buy rating on Okta stock, maintains $130 price target
PositiveFinancial Markets
Stifel has reaffirmed its Buy rating on Okta's stock and is maintaining a price target of $130. This is significant as it reflects confidence in Okta's growth potential and market position, which could encourage investors to consider the stock as a viable option for their portfolios.
Stifel raises Alnylam Pharmaceuticals stock price target to $495 on strong Vutrisiran sales
PositiveFinancial Markets
Stifel has raised its price target for Alnylam Pharmaceuticals to $495, driven by strong sales of Vutrisiran. This increase reflects confidence in the company's growth and the effectiveness of its products, which is great news for investors and the market. As Vutrisiran continues to perform well, it highlights Alnylam's position in the pharmaceutical industry and its potential for future success.
IsoEnergy stock rating resumed at Buy by Stifel on dual-market strategy
PositiveFinancial Markets
IsoEnergy has received a positive boost as Stifel has resumed its stock rating at 'Buy', highlighting the company's dual-market strategy. This is significant because it reflects confidence in IsoEnergy's potential for growth and profitability, especially in a competitive market. Investors may see this as a strong indicator of the company's future performance.
Latest from Financial Markets
Fears of Economic Turmoil Deepen in France as Another Prime Minister Quits
NegativeFinancial Markets
France is facing increasing fears of economic turmoil following the resignation of another prime minister, raising concerns about the stability of the government and its ability to address pressing economic issues. This situation is significant as it could lead to further political instability, impacting both domestic policies and international relations.
Can Cory Doctorow’s Book ‘Enshittification’ Change the Tech Debate?
PositiveFinancial Markets
Cory Doctorow's new book 'Enshittification' is stirring up discussions in the tech world, challenging the status quo of how technology companies operate. By addressing the negative impacts of corporate practices on users and society, Doctorow aims to inspire a shift in the tech debate towards more ethical and user-centered approaches. This matters because it encourages critical thinking about the role of technology in our lives and the responsibilities of those who create it.
Credit Agricole Delays Canadian Dollar Bond Sale
NegativeFinancial Markets
Credit Agricole SA has postponed its planned sale of a 10-year Canadian dollar bond following the unexpected resignation of France's prime minister. This delay highlights the potential impact of political instability on financial markets, as investors often react cautiously to such developments. The bond market's response could influence future financing strategies for the bank and other institutions.
Paramount Buys Bari Weiss’s Free Press, Starting a New Era at CBS News
PositiveFinancial Markets
Paramount's acquisition of Bari Weiss's Free Press marks a significant shift in the landscape of CBS News, signaling a commitment to diverse perspectives in journalism. This move is important as it reflects the growing trend of media companies seeking to adapt to changing audience preferences and the demand for more varied narratives in news reporting.
Taylor Swift KO’s The Rock with top box office spot as ‘Official Release Party of a Show Girl’ rakes in $33 million
PositiveFinancial Markets
Taylor Swift has made a remarkable impact at the box office, surpassing The Rock with her latest release, 'Official Release Party of a Show Girl,' which grossed $33 million. This achievement highlights Swift's ability to captivate audiences and demonstrates her innovative approach to merging music and film. Media analyst Paul Dergarabedian praised her strategy, calling it a stroke of genius, which underscores the significance of her influence in the entertainment industry.
ChatGPT users can now connect to third-party apps like Spotify and Zillow
PositiveFinancial Markets
ChatGPT users can now enhance their experience by connecting to third-party applications like Spotify and Zillow. This integration allows for a more personalized interaction, enabling users to access music and real estate information seamlessly. It's a significant step forward in making AI more versatile and user-friendly, reflecting the growing trend of integrating AI with everyday tools.